Connect with us

Health

Improving the Identification of Therapeutic Vulnerabilities in Breast Cancer – OncoZine

Researchers at Baylor College of Medicine, the Broad Institute of MIT, and Harvard have applied powerful proteogenomics approaches to better understand the biological…

Published

on

post featured image

Researchers at Baylor College of Medicine, the Broad Institute of MIT, and Harvard have applied powerful proteogenomics approaches to better understand the biological complexity of breast cancer.
Matthew Ellis MD, BChir, BSc., Ph.D., FRCP, serves as director of the Lester and Sue Smith Breast Center at Baylor. He is a world-renowned clinician and researcher of the molecular profiling of breast cancer. Ellis is a native of the United Kingdom.
Proteogenomics is an approach to tumor profiling that…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending